Hikma Pharmaceuticals PLC (HKMPY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 02:20PM EDT. Market open.
| Previous close | 46.16 |
| Open | 46.16 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 46.16 - 46.16 |
| 52-week range | 42.23 - 56.63 |
| Volume | |
| Avg. volume | 140 |
| Market cap | 5.361B |
| Beta (5Y monthly) | 0.44 |
| PE ratio (TTM) | 27.15 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.44 (3.12%) |
| Ex-dividend date | 21 Mar 2024 |
| 1y target est | N/A |
- Simply Wall St.
With 52% institutional ownership, Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst the big guns
Key Insights Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to...
- Fool.co.uk
I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April
I want to increase my exposure to the pharmaceuticals industry this year, so I've been looking for undervalued stocks to buy with strong growth potential. The post I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April appeared first on The Motley Fool UK.
- Fool.co.uk
2 FTSE 100 shares investors should consider buying for a winning portfolio
Our writer details two FTSE 100 shares that she thinks could help build a great portfolio of stocks to boost long-term wealth. The post 2 FTSE 100 shares investors should consider buying for a winning portfolio appeared first on The Motley Fool UK.
© 2024 Yahoo. All rights reserved.